Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablet
Recalled March 11, 2026 · FDA recall D-0356-2026 · Teva Pharmaceuticals USA
Hazard
Failed Dissolution Specifications · FDA Class II
Units
7,448 bottles
Sold at
Nationwide
Description
Failed Dissolution Specifications
Product
Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054.
Manufacturer(s)
Teva Pharmaceuticals USA, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →